Jazz Pharmaceuticals Statistics
Total Valuation
JAZZ has a market cap or net worth of $7.61 billion. The enterprise value is $11.19 billion.
Important Dates
The next estimated earnings date is Wednesday, February 26, 2025, after market close.
Earnings Date | Feb 26, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
JAZZ has 60.45 million shares outstanding. The number of shares has decreased by -2.29% in one year.
Current Share Class | 60.45M |
Shares Outstanding | 60.45M |
Shares Change (YoY) | -2.29% |
Shares Change (QoQ) | -9.27% |
Owned by Insiders (%) | 2.87% |
Owned by Institutions (%) | 98.02% |
Float | 58.67M |
Valuation Ratios
The trailing PE ratio is 17.88 and the forward PE ratio is 5.88. JAZZ's PEG ratio is 0.38.
PE Ratio | 17.88 |
Forward PE | 5.88 |
PS Ratio | 1.96 |
Forward PS | 1.77 |
PB Ratio | 1.82 |
P/TBV Ratio | n/a |
P/FCF Ratio | 6.73 |
P/OCF Ratio | 6.53 |
PEG Ratio | 0.38 |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 7.37, with an EV/FCF ratio of 9.91.
EV / Earnings | 24.17 |
EV / Sales | 2.80 |
EV / EBITDA | 7.37 |
EV / EBIT | 12.90 |
EV / FCF | 9.91 |
Financial Position
The company has a current ratio of 4.26, with a Debt / Equity ratio of 1.49.
Current Ratio | 4.26 |
Quick Ratio | 3.24 |
Debt / Equity | 1.49 |
Debt / EBITDA | 4.02 |
Debt / FCF | 5.49 |
Interest Coverage | 2.46 |
Financial Efficiency
Return on equity (ROE) is 12.09% and return on invested capital (ROIC) is 5.52%.
Return on Equity (ROE) | 12.09% |
Return on Assets (ROA) | 4.62% |
Return on Capital (ROIC) | 5.52% |
Revenue Per Employee | $1.43M |
Profits Per Employee | $165,414 |
Employee Count | 2,800 |
Asset Turnover | 0.34 |
Inventory Turnover | 0.51 |
Taxes
Income Tax | -66.61M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +3.77% in the last 52 weeks. The beta is 0.57, so JAZZ's price volatility has been lower than the market average.
Beta (5Y) | 0.57 |
52-Week Price Change | +3.77% |
50-Day Moving Average | 119.35 |
200-Day Moving Average | 112.84 |
Relative Strength Index (RSI) | 60.26 |
Average Volume (20 Days) | 590,545 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, JAZZ had revenue of $3.99 billion and earned $463.16 million in profits. Earnings per share was $7.04.
Revenue | 3.99B |
Gross Profit | 3.70B |
Operating Income | 867.63M |
Pretax Income | 295.68M |
Net Income | 463.16M |
EBITDA | 1.52B |
EBIT | 867.63M |
Earnings Per Share (EPS) | $7.04 |
Full Income Statement Balance Sheet
The company has $2.62 billion in cash and $6.20 billion in debt, giving a net cash position of -$3.59 billion or -$59.32 per share.
Cash & Cash Equivalents | 2.62B |
Total Debt | 6.20B |
Net Cash | -3.59B |
Net Cash Per Share | -$59.32 |
Equity (Book Value) | 4.17B |
Book Value Per Share | 69.01 |
Working Capital | 3.36B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $1.16 billion and capital expenditures -$34.89 million, giving a free cash flow of $1.13 billion.
Operating Cash Flow | 1.16B |
Capital Expenditures | -34.89M |
Free Cash Flow | 1.13B |
FCF Per Share | $18.69 |
Full Cash Flow Statement Margins
Gross margin is 92.62%, with operating and profit margins of 21.73% and 11.60%.
Gross Margin | 92.62% |
Operating Margin | 21.73% |
Pretax Margin | 9.93% |
Profit Margin | 11.60% |
EBITDA Margin | 38.03% |
EBIT Margin | 21.73% |
FCF Margin | 28.30% |
Dividends & Yields
JAZZ does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 2.29% |
Shareholder Yield | 2.29% |
Earnings Yield | 6.09% |
FCF Yield | 14.85% |
Dividend Details Analyst Forecast
The average price target for JAZZ is $173.93, which is 38.24% higher than the current price. The consensus rating is "Buy".
Price Target | $173.93 |
Price Target Difference | 38.24% |
Analyst Consensus | Buy |
Analyst Count | 14 |
Revenue Growth Forecast (5Y) | 5.42% |
EPS Growth Forecast (5Y) | 24.92% |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
JAZZ has an Altman Z-Score of 1.54 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.54 |
Piotroski F-Score | 6 |